These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 18831896)

  • 1. Cellular distribution of tumour suppressor protein p53 and high-risk human papillomavirus (HPV)-18 E6 fusion protein in wild-type p53 cell lines.
    Sun L; Zhang G; Li Z; Lei T; Huang C; Song T; Si L
    J Int Med Res; 2008; 36(5):1015-21. PubMed ID: 18831896
    [TBL] [Abstract][Full Text] [Related]  

  • 2. GFP/HPV-16E6 fusion protein induces apoptosis in MCF-7 and 293T cells using a transient expression system.
    Zhang G; Liu Y; Yu L; Sun L
    Oncol Rep; 2012 Nov; 28(5):1673-80. PubMed ID: 22922869
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The location of endogenous wild-type p53 protein in 293T and HEK293 cells expressing low-risk HPV-6E6 fusion protein with GFP.
    Sun L; Shen X; Liu Y; Zhang G; Wei J; Zhang H; Zhang E; Ma F
    Acta Biochim Biophys Sin (Shanghai); 2010 Mar; 42(3):230-5. PubMed ID: 20213049
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In GFP with high risk HPV-18E6 fusion protein expressed 293T and MCF-7 cells, the endogenous wild-type p53 could be transiently phosphorylated at multiple sites.
    Sun L; Zhang G; Li Z; Song T; Huang C; Si L
    J Exp Clin Cancer Res; 2008 Sep; 27(1):35. PubMed ID: 18778462
    [TBL] [Abstract][Full Text] [Related]  

  • 5. HPV-16E6 can induce multiple site phosphorylation of p53.
    Zhang G; Sun L; Li Z; Si L; Song T; Huang C; Zhang W
    Oncol Rep; 2009 Feb; 21(2):371-7. PubMed ID: 19148510
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Functional inactivation of p73, a homolog of p53 tumor suppressor protein, by human papillomavirus E6 proteins.
    Park JS; Kim EJ; Lee JY; Sin HS; Namkoong SE; Um SJ
    Int J Cancer; 2001 Mar; 91(6):822-7. PubMed ID: 11275986
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Two different HPV-11E6 fusion proteins trap p53 in the cytoplasm and induce apoptosis.
    Sun L; Zhang G; Lei T; Huang C; Song T; Si L
    Cancer Biol Ther; 2008 Dec; 7(12):1909-15. PubMed ID: 18981731
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Repression of human papillomavirus oncogenes in HeLa cervical carcinoma cells causes the orderly reactivation of dormant tumor suppressor pathways.
    Goodwin EC; DiMaio D
    Proc Natl Acad Sci U S A; 2000 Nov; 97(23):12513-8. PubMed ID: 11070078
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Alternatively spliced HPV-18 E6* protein inhibits E6 mediated degradation of p53 and suppresses transformed cell growth.
    Pim D; Massimi P; Banks L
    Oncogene; 1997 Jul; 15(3):257-64. PubMed ID: 9233760
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intracellular Analysis of the Interaction between the Human Papillomavirus Type 16 E6 Oncoprotein and Inhibitory Peptides.
    Stutz C; Reinz E; Honegger A; Bulkescher J; Schweizer J; Zanier K; Travé G; Lohrey C; Hoppe-Seyler K; Hoppe-Seyler F
    PLoS One; 2015; 10(7):e0132339. PubMed ID: 26151636
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of human papillomavirus type 18 (HPV-18) E6-mediated degradation of p53 in vitro and in vivo reveals significant differences based on p53 structure and cell type but little difference with respect to mutants of HPV-18 E6.
    Gardiol D; Banks L
    J Gen Virol; 1998 Aug; 79 ( Pt 8)():1963-70. PubMed ID: 9714244
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of E6 induced degradation of p53 is not sufficient for stabilization of p53 protein in cervical tumour derived cell lines.
    Mantovani F; Banks L
    Oncogene; 1999 Jun; 18(22):3309-15. PubMed ID: 10362351
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunohistochemical co-expression of human papillomavirus type 16/18 transforming (E6) oncoprotein and p53 tumour suppressor gene proteins in oesophageal cancer.
    Agarwal SK; Chatterji A; Bhambhani S; Sharma BK
    Indian J Exp Biol; 1998 Jun; 36(6):559-63. PubMed ID: 9731468
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Regulation of p14ARF expression by HPV-18 E6 variants.
    Vazquez-Vega S; Sanchez-Suarez LP; Andrade-Cruz R; Castellanos-Juarez E; Contreras-Paredes A; Lizano-Soberon M; Garcia-Carranca A; Benitez Bribiesca L
    J Med Virol; 2013 Jul; 85(7):1215-21. PubMed ID: 23918540
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Star-PAP controls HPV E6 regulation of p53 and sensitizes cells to VP-16.
    Li W; Anderson RA
    Oncogene; 2014 Feb; 33(7):928-32. PubMed ID: 23416977
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A novel peptide motif binding to and blocking the intracellular activity of the human papillomavirus E6 oncoprotein.
    Dymalla S; Scheffner M; Weber E; Sehr P; Lohrey C; Hoppe-Seyler F; Hoppe-Seyler K
    J Mol Med (Berl); 2009 Mar; 87(3):321-31. PubMed ID: 19099279
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The domain of p53 required for binding HPV 16 E6 is separable from the degradation domain.
    Mansur CP; Marcus B; Dalal S; Androphy EJ
    Oncogene; 1995 Feb; 10(3):457-65. PubMed ID: 7845670
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A single-codon mutation converts HPV16 E6 oncoprotein into a potential tumor suppressor, which induces p53-dependent senescence of HPV-positive HeLa cervical cancer cells.
    Ristriani T; Fournane S; Orfanoudakis G; Travé G; Masson M
    Oncogene; 2009 Feb; 28(5):762-72. PubMed ID: 19015633
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Targeting the Two Oncogenic Functional Sites of the HPV E6 Oncoprotein with a High-Affinity Bivalent Ligand.
    Ramirez J; Poirson J; Foltz C; Chebaro Y; Schrapp M; Meyer A; Bonetta A; Forster A; Jacob Y; Masson M; Deryckère F; Travé G
    Angew Chem Int Ed Engl; 2015 Jun; 54(27):7958-62. PubMed ID: 26014966
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chemotherapy compounds in cervical cancer cells primed by reconstitution of p53 function after short interfering RNA-mediated degradation of human papillomavirus 18 E6 mRNA: opposite effect of siRNA in combination with different drugs.
    Koivusalo R; Krausz E; Helenius H; Hietanen S
    Mol Pharmacol; 2005 Aug; 68(2):372-82. PubMed ID: 15908516
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.